180 related articles for article (PubMed ID: 24403257)
1. Expression profiling of cervical cancers in Indian women at different stages to identify gene signatures during progression of the disease.
Thomas A; Mahantshetty U; Kannan S; Deodhar K; Shrivastava SK; Kumar-Sinha C; Mulherkar R
Cancer Med; 2013 Dec; 2(6):836-48. PubMed ID: 24403257
[TBL] [Abstract][Full Text] [Related]
2. Microarray analysis of normal cervix, carcinoma in situ, and invasive cervical cancer: identification of candidate genes in pathogenesis of invasion in cervical cancer.
Song JY; Lee JK; Lee NW; Jung HH; Kim SH; Lee KW
Int J Gynecol Cancer; 2008; 18(5):1051-9. PubMed ID: 18217980
[TBL] [Abstract][Full Text] [Related]
3. Genome-wide gene expression profiling of cervical cancer in Hong Kong women by oligonucleotide microarray.
Wong YF; Cheung TH; Tsao GS; Lo KW; Yim SF; Wang VW; Heung MM; Chan SC; Chan LK; Ho TW; Wong KW; Li C; Guo Y; Chung TK; Smith DI
Int J Cancer; 2006 May; 118(10):2461-9. PubMed ID: 16353136
[TBL] [Abstract][Full Text] [Related]
4. Identification and characterization of genes involved in the carcinogenesis of human squamous cell cervical carcinoma.
Cheng Q; Lau WM; Tay SK; Chew SH; Ho TH; Hui KM
Int J Cancer; 2002 Mar; 98(3):419-26. PubMed ID: 11920594
[TBL] [Abstract][Full Text] [Related]
5. Assessment of a six gene panel for the molecular detection of circulating tumor cells in the blood of female cancer patients.
Obermayr E; Sanchez-Cabo F; Tea MK; Singer CF; Krainer M; Fischer MB; Sehouli J; Reinthaller A; Horvat R; Heinze G; Tong D; Zeillinger R
BMC Cancer; 2010 Dec; 10():666. PubMed ID: 21129172
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the microRNA profile in early-stage cervical squamous cell carcinoma by next-generation sequencing.
Lin W; Feng M; Chen G; Zhou Z; Li J; Ye Y
Oncol Rep; 2017 Mar; 37(3):1477-1486. PubMed ID: 28098890
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of eukaryotic initiation factor 5A2 (EIF5A2) is associated with cancer progression and poor prognosis in patients with early-stage cervical cancer.
Yang SS; Gao Y; Wang DY; Xia BR; Liu YD; Qin Y; Ning XM; Li GY; Hao LX; Xiao M; Zhang YY
Histopathology; 2016 Aug; 69(2):276-87. PubMed ID: 26799253
[TBL] [Abstract][Full Text] [Related]
8. Distinct DNA methylation profiles between adenocarcinoma and squamous cell carcinoma of human uterine cervix.
Lee EJ; Mcclelland M; Wang Y; Long F; Choi SH; Lee JH
Oncol Res; 2010; 18(9):401-8. PubMed ID: 20524398
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic and prognostic significance of miRNA signatures in tissues and plasma of endometrioid endometrial carcinoma patients.
Torres A; Torres K; Pesci A; Ceccaroni M; Paszkowski T; Cassandrini P; Zamboni G; Maciejewski R
Int J Cancer; 2013 Apr; 132(7):1633-45. PubMed ID: 22987275
[TBL] [Abstract][Full Text] [Related]
10. Variation in apoptotic gene expression in cervical cancer through oligonucleotide microarray profiling.
Zhu MY; Chen F; Niyazi M; Sui S; Gao DM
J Low Genit Tract Dis; 2015 Jan; 19(1):46-54. PubMed ID: 24914885
[TBL] [Abstract][Full Text] [Related]
11. Differential gene expression identified in Uigur women cervical squamous cell carcinoma by suppression subtractive hybridization.
Pan Z; Chen S; Pan X; Wang Z; Han H; Zheng W; Wang X; Li F; Qu S; Shao R
Neoplasma; 2010; 57(2):123-8. PubMed ID: 20099975
[TBL] [Abstract][Full Text] [Related]
12. Gene expression profiling in two morphologically different uterine cervical carcinoma cell lines derived from a single donor using a human cancer cDNA array.
Fujimoto T; Nishikawa A; Iwasaki M; Akutagawa N; Teramoto M; Kudo R
Gynecol Oncol; 2004 May; 93(2):446-53. PubMed ID: 15099960
[TBL] [Abstract][Full Text] [Related]
13. Gene expression profiles of primary HPV16- and HPV18-infected early stage cervical cancers and normal cervical epithelium: identification of novel candidate molecular markers for cervical cancer diagnosis and therapy.
Santin AD; Zhan F; Bignotti E; Siegel ER; Cané S; Bellone S; Palmieri M; Anfossi S; Thomas M; Burnett A; Kay HH; Roman JJ; O'Brien TJ; Tian E; Cannon MJ; Shaughnessy J; Pecorelli S
Virology; 2005 Jan; 331(2):269-91. PubMed ID: 15629771
[TBL] [Abstract][Full Text] [Related]
14. Gene expression signatures of angiocidin and darapladib treatment connect to therapy options in cervical cancer.
Koch M; Wiese M
J Cancer Res Clin Oncol; 2013 Feb; 139(2):259-67. PubMed ID: 23052694
[TBL] [Abstract][Full Text] [Related]
15. Aberrant expression of microRNA-26b and its prognostic potential in human cervical cancer.
Luo M; Shen D; Wang W; Xian J
Int J Clin Exp Pathol; 2015; 8(5):5542-8. PubMed ID: 26191262
[TBL] [Abstract][Full Text] [Related]
16. DNA microchips to identify molecular signatures in cervical cancers.
Wong YF; Chung TK; Wang VW; Smith DI
Methods Mol Biol; 2007; 385():87-101. PubMed ID: 18365706
[TBL] [Abstract][Full Text] [Related]
17. An integrated approach for mining precise RNA-based cervical cancer staging biomarkers.
Banerjee S; Karunagaran D
Gene; 2019 Sep; 712():143961. PubMed ID: 31279709
[TBL] [Abstract][Full Text] [Related]
18. Potential mechanism of RRM2 for promoting Cervical Cancer based on weighted gene co-expression network analysis.
Wang J; Yi Y; Chen Y; Xiong Y; Zhang W
Int J Med Sci; 2020; 17(15):2362-2372. PubMed ID: 32922202
[TBL] [Abstract][Full Text] [Related]
19. Expression genomics of cervical cancer: molecular classification and prediction of radiotherapy response by DNA microarray.
Wong YF; Selvanayagam ZE; Wei N; Porter J; Vittal R; Hu R; Lin Y; Liao J; Shih JW; Cheung TH; Lo KW; Yim SF; Yip SK; Ngong DT; Siu N; Chan LK; Chan CS; Kong T; Kutlina E; McKinnon RD; Denhardt DT; Chin KV; Chung TK
Clin Cancer Res; 2003 Nov; 9(15):5486-92. PubMed ID: 14654527
[TBL] [Abstract][Full Text] [Related]
20. microRNA-944 overexpression is a biomarker for poor prognosis of advanced cervical cancer.
Park S; Kim J; Eom K; Oh S; Kim S; Kim G; Ahn S; Park KH; Chung D; Lee H
BMC Cancer; 2019 May; 19(1):419. PubMed ID: 31060525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
